PODCAST · health
Oral Tirzepatide — The Future of Weight Loss Pills
by Inception Point AI
Eli Lilly's orforglipron achieved 27 pounds of weight loss in trials, potentially revolutionizing obesity treatment with a daily pill that needs no refrigeration. Dr. Ben Synth examines the science behind oral GLP-1 drugs, their potential to democratize access worldwide, and the dangers of unregulated compounded alternatives that harmed hundreds of patients.For more content like this, visit QuietPlease.ai
No episodes available yet.
No matches for "" in this podcast's transcripts.
No topics indexed yet for this podcast.
Loading reviews...
ABOUT THIS SHOW
Eli Lilly's orforglipron achieved 27 pounds of weight loss in trials, potentially revolutionizing obesity treatment with a daily pill that needs no refrigeration. Dr. Ben Synth examines the science behind oral GLP-1 drugs, their potential to democratize access worldwide, and the dangers of unregulated compounded alternatives that harmed hundreds of patients.For more content like this, visit QuietPlease.ai
HOSTED BY
Inception Point AI
Loading similar podcasts...
URL copied to clipboard!